BioRestorative Therapies files Exhibit 10.1
The company filed an exhibit 10.1 to its 8-K report, though specific terms of the agreement were not included in the provided text.
View filing at SEC.gov →3 most recent filings and news items mentioning BRTX. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/BRTX/news?limit=20"
Pull BRTX filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayThe company filed an exhibit 10.1 to its 8-K report, though specific terms of the agreement were not included in the provided text.
View filing at SEC.gov →BioRestorative Therapies, Inc. executed a revolving loan agreement with an unnamed lender providing access to capital on an as-needed basis up to a maximum outstanding amount. The facility provides financial flexibility for the biotech company's operational and strategic needs.
View filing at SEC.gov →BioRestorative Therapies filed a certificate of amendment to its articles of incorporation with the SEC. The filing indicates a corporate governance or structural modification but specific details of the amendment are not disclosed in the document reference.
View filing at SEC.gov →